Phase II Trial of Atezolizumab in BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Atezolizumab (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 16 Feb 2018 Trial design presented at the 2018 Genitourinary Cancers Symposium.
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 18 Apr 2017 Planned primary completion date changed from 28 Feb 2019 to 1 Feb 2019.